Prot #LP0162-1337: Long-term extension trial in subjects with atopic dermatitis who participated in previous tralokinumab trials – ECZTEND

Project: Research project

Project Details

StatusFinished
Effective start/end date3/1/198/31/24

Funding

  • LEO Pharma Inc ((OE) Prot #LP0162-1337)